Janus kinase 1/2 inhibition for the treatment of autoinflammation associated with heterozygous TNFAIP3 mutation

Detalles Bibliográficos
Autores principales: Mulhern, Ciara M., Hong, Ying, Omoyinmi, Ebun, Jacques, Thomas S., D'Arco, Felice, Hemingway, Cheryl, Brogan, Paul A., Eleftheriou, Despina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mosby 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721833/
https://www.ncbi.nlm.nih.gov/pubmed/31175876
http://dx.doi.org/10.1016/j.jaci.2019.05.026
_version_ 1783448431415525376
author Mulhern, Ciara M.
Hong, Ying
Omoyinmi, Ebun
Jacques, Thomas S.
D'Arco, Felice
Hemingway, Cheryl
Brogan, Paul A.
Eleftheriou, Despina
author_facet Mulhern, Ciara M.
Hong, Ying
Omoyinmi, Ebun
Jacques, Thomas S.
D'Arco, Felice
Hemingway, Cheryl
Brogan, Paul A.
Eleftheriou, Despina
author_sort Mulhern, Ciara M.
collection PubMed
description
format Online
Article
Text
id pubmed-6721833
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Mosby
record_format MEDLINE/PubMed
spelling pubmed-67218332019-09-06 Janus kinase 1/2 inhibition for the treatment of autoinflammation associated with heterozygous TNFAIP3 mutation Mulhern, Ciara M. Hong, Ying Omoyinmi, Ebun Jacques, Thomas S. D'Arco, Felice Hemingway, Cheryl Brogan, Paul A. Eleftheriou, Despina J Allergy Clin Immunol Article Mosby 2019-09 /pmc/articles/PMC6721833/ /pubmed/31175876 http://dx.doi.org/10.1016/j.jaci.2019.05.026 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Mulhern, Ciara M.
Hong, Ying
Omoyinmi, Ebun
Jacques, Thomas S.
D'Arco, Felice
Hemingway, Cheryl
Brogan, Paul A.
Eleftheriou, Despina
Janus kinase 1/2 inhibition for the treatment of autoinflammation associated with heterozygous TNFAIP3 mutation
title Janus kinase 1/2 inhibition for the treatment of autoinflammation associated with heterozygous TNFAIP3 mutation
title_full Janus kinase 1/2 inhibition for the treatment of autoinflammation associated with heterozygous TNFAIP3 mutation
title_fullStr Janus kinase 1/2 inhibition for the treatment of autoinflammation associated with heterozygous TNFAIP3 mutation
title_full_unstemmed Janus kinase 1/2 inhibition for the treatment of autoinflammation associated with heterozygous TNFAIP3 mutation
title_short Janus kinase 1/2 inhibition for the treatment of autoinflammation associated with heterozygous TNFAIP3 mutation
title_sort janus kinase 1/2 inhibition for the treatment of autoinflammation associated with heterozygous tnfaip3 mutation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721833/
https://www.ncbi.nlm.nih.gov/pubmed/31175876
http://dx.doi.org/10.1016/j.jaci.2019.05.026
work_keys_str_mv AT mulhernciaram januskinase12inhibitionforthetreatmentofautoinflammationassociatedwithheterozygoustnfaip3mutation
AT hongying januskinase12inhibitionforthetreatmentofautoinflammationassociatedwithheterozygoustnfaip3mutation
AT omoyinmiebun januskinase12inhibitionforthetreatmentofautoinflammationassociatedwithheterozygoustnfaip3mutation
AT jacquesthomass januskinase12inhibitionforthetreatmentofautoinflammationassociatedwithheterozygoustnfaip3mutation
AT darcofelice januskinase12inhibitionforthetreatmentofautoinflammationassociatedwithheterozygoustnfaip3mutation
AT hemingwaycheryl januskinase12inhibitionforthetreatmentofautoinflammationassociatedwithheterozygoustnfaip3mutation
AT broganpaula januskinase12inhibitionforthetreatmentofautoinflammationassociatedwithheterozygoustnfaip3mutation
AT eleftherioudespina januskinase12inhibitionforthetreatmentofautoinflammationassociatedwithheterozygoustnfaip3mutation

Ejemplares similares